Stocks and Investing Stocks and Investing
Mon, August 10, 2015
Fri, August 7, 2015
Thu, August 6, 2015
Wed, August 5, 2015

Andrew Peters Maintained (BMRN) at Strong Buy with Increased Target to $160 on, Aug 5th, 2015


Published on 2024-10-25 09:38:25 -
  Print publication without navigation


Andrew Peters of Deutsche Bank, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $156 to $160 on, Aug 5th, 2015.

Andrew has made no other calls on BMRN in the last 4 months.



There are 5 other peers that have a rating on BMRN. Out of the 5 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Andrew


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $168 on, Tuesday, August 4th, 2015
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $151 on, Thursday, June 18th, 2015
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $156 on, Thursday, June 18th, 2015
  • Kennen MacKay of "RBC Capital" Maintained at Buy with Increased Target to $145 on, Thursday, June 18th, 2015
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $150 on, Thursday, June 18th, 2015